| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922354 Methods and system for processing dispersible fine powders |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922322 Cleaves at the gamma glycine404-alanine405 peptide bond; apply to medical equipment to inhibit thrombus formation; administering to treat restenosis post-surgery, to inhibit vascular reocclusion |
| 07/13/1999 | US5922315 Adenoviruses having altered hexon proteins |
| 07/13/1999 | US5922253 Production scale method of forming microparticles |
| 07/08/1999 | WO1999034017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | WO1999034007A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | WO1999033999A1 Mitogen-activated protein kinase kinase 7 (mkk7) |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033977A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | WO1999033976A1 Polypeptide, their production and use |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033342A1 Method of suppressing tumor cell growth by administering decorin |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/08/1999 | WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | CA2317111A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | CA2316396A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | CA2316017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2313246A1 Polypeptide, their production and use |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927263A1 Recombinase-mediated generation of adenoviral vectors |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927174A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927044A1 Targeted viral vectors |
| 07/07/1999 | EP0927043A1 Method for gene transfer to the central nervous system |
| 07/07/1999 | EP0743948B1 Separation of nucleic acids by chromatography |
| 07/07/1999 | EP0527916B1 Antisense inhibitors of the human immunodeficiency virus |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1221796A Biologically tolerated low molecular weight polyethylenimines |
| 07/07/1999 | CN1221749A Antisensedigonucleotides for inhibiting human body tumour cell growth |
| 07/06/1999 | US5919912 Mammalian IAP antibodies and diagnostic kits |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919763 IL-6/SIL-6R complex for promotion of liver functions |
| 07/06/1999 | US5919701 Oligonucleotides with activity against human immunodeficiency virus |
| 07/06/1999 | US5919676 Isolated cell concurrently infected with helper adenovirus with packaging signals flanked by recombinase sites and replication/packaging competant helper-dependent vector with deletion to 35,000 base pairs for insertion of exogenous dna |
| 07/06/1999 | US5919667 Modular assembly retroviral vectors and uses thereof |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919656 Genes encoding telomerase protein 1 |
| 07/06/1999 | US5919653 A recombinantly altered nucleotide sequence that codes for a neurotransmitter protein; treatment of epilepsy, stroke, multiple sclerosis, spinal cord injury, and other nervous system disorders |
| 07/06/1999 | US5919652 Anticarcinogenic agents, antitumor agents for vectors used in gene therapy |
| 07/06/1999 | US5919650 Introducing recombinant dna encoding an antibody/fragment that binds the protein in mammalian cells, expressing the protein intracellularly, allowing antibody to bind oncogenic protein; anticarcinogenic/antitumor agents |
| 07/06/1999 | US5919442 Hyper comb-branched polymer conjugates |
| 07/01/1999 | WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 07/01/1999 | WO1999032647A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | WO1999032646A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032633A1 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
| 07/01/1999 | WO1999032632A1 Novel embryo-derived interleukin related factor molecules and uses therefor |
| 07/01/1999 | WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032606A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032503A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | WO1999032149A1 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER) |
| 07/01/1999 | WO1999032147A1 Immunization for ebola virus infection |
| 07/01/1999 | WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | WO1999031982A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | WO1999020742A3 A packaging cell line producing siv-pseudotyped mlv |
| 07/01/1999 | WO1999018933A3 Methods for encapsulating nucleic acids in lipid bilayers |
| 07/01/1999 | WO1999011292A3 Compositions and methods for treating arthritis utilizing gene therapy |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | DE19752855A1 Retrovirale Pseudotyp-Vektoren mit modifizierten Oberflächen-Hüllproteinen und Verfahren zu ihrer Herstellung für den selektiven Gentransfer Retroviral vectors pseudotyped with modified surface envelope proteins and methods for their preparation for selective gene transfer |
| 07/01/1999 | DE19752854A1 Cell-specific retroviral vectors with antibody domains suitable for cell-specific transduction of selected mammal cell types |
| 07/01/1999 | CA2316414A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | CA2316321A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315269A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | CA2315032A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | CA2314905A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 06/30/1999 | EP0926677A2 Method and system for producing personal golf lesson video |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926157A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 06/30/1999 | EP0926156A2 Vector comprising Mycobacterium tuberculosis 38 kDa antigen for neoplasm treatment |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/30/1999 | EP0925357A1 Human cns cell lines and methods of use therefor |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925074A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 06/30/1999 | EP0725141A4 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221033A Oncogene- or virus-controlled expression systems |